Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcīnas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
Latvija -
latviešu -
Pārtikas un veterinārais dienests, Zemkopības ministrija
ostrovit® technology of nutrition gotu kola (2023.) kapsula
kapsula
Latvija -
latviešu -
Zāļu valsts aģentūra
trachisan sūkājamās tabletes
engelhard arzneimittel gmbh & co.kg, germany - tyrothricinum, lidocaini hydrochloridum, chlorhexidini digluconas - sūkājamā tablete
Latvija -
latviešu -
Zāļu valsts aģentūra
skinoren 200 mg/g krēms
leo pharma a/s, denmark - azelaīnskābe - krēms - 200 mg/g
Latvija -
latviešu -
Zāļu valsts aģentūra
testim 50 mg gels
ferring hellas, greece - testosterons - gels - 50 mg
Latvija -
latviešu -
Zāļu valsts aģentūra
aklief 50 mikrogrami/g krēms
galderma international, france - trifarotenum - krēms - 50 µg/g